IBBQ Invesco Nasdaq Biotechnology ETF
34.27
-0.345 (-1.00%)
기준 시세 Oct 12, 2026 18:38 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
이 ETF 소개
The Invesco Nasdaq Biotechnology ETF (IBBQ) seeks to mirror the investment performance of the Nasdaq Biotechnology Index. To achieve this, the Fund generally dedicates at least 90% of its total capital to the securities that make up this benchmark index. The underlying Index itself is specifically designed to gauge the returns of biotechnology and pharmaceutical companies whose shares are publicly traded on the Nasdaq Stock Market. Both the ETF and its corresponding Index undergo a yearly review and update of their composition each December, and their weightings are adjusted quarterly in March, June, September, and December.
펀드 데이터 제공업체의 설명 · 기준 프로필 Oct 12, 2026.
가격 차트
일별 종가 기준 (가격 수익률, 총수익률 아님). 비교 선은 기간 시작 시점 대비 등락률로 정규화됩니다. 출처: Financial Modeling Prep.
성과
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | 설정일* | |
|---|---|---|---|---|---|---|---|---|---|
| 가격 수익률 | -0.89% | +4.62% | +19.09% | +21.90% | +35.55% | +20.29% | +7.11% | — | +5.84% |
| 총수익률 | -0.89% | +4.62% | +19.21% | +22.16% | +36.25% | +21.31% | +8.05% | — | +6.75% |
* 연환산 수치입니다. 총 수익률은 배당 재투자를 반영한 수정 주가 기준이며, 가격 수익률은 수정되지 않은 종가 기준입니다. 성과 기준일 Oct 09, 2026. 과거 성과가 미래 수익을 보장하지 않습니다.
수수료
| 순 보수율 | 0.19% | $10,000 투자 시 연간 비용 | $19.00 |
예시 계산 전용: 보수율 × $10,000. 매매 비용, 매수/매도 스프레드, 세금 및 투자 가치 변동은 제외됩니다. 총보수 및 순보수 세부 내용과 수수료 면제 사항은 투자설명서를 참고하시기 바랍니다.
보유 종목
기준일 보유 종목 Oct 10, 2026 · 데이터 제공업체의 포트폴리오 보고 기준일; 보유 종목은 실시간 포지션이 아닙니다. 257 데이터베이스 내 행 수.
| # | 보유 종목 | 티커 | 비중 | 주식 | 시장 가치 |
|---|---|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 8.41% | 62.14K | $9.4M |
| 2 | Amgen Inc | AMGN | 7.87% | 21.17K | $8.8M |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 7.63% | 16.71K | $8.5M |
| 4 | Moderna Inc | MRNA | 5.99% | 29.72K | $6.7M |
| 5 | Regeneron Pharmaceuticals Inc | REGN | 5.03% | 7.52K | $5.6M |
| 6 | Illumina Inc | ILMN | 2.80% | 11.24K | $3.1M |
| 7 | Revolution Medicines Inc | RVMD | 2.71% | 15.95K | $3.0M |
| 8 | Biogen Inc | BIIB | 2.22% | 11.00K | $2.5M |
| 9 | Alnylam Pharmaceuticals Inc | ALNY | 2.08% | 9.96K | $2.3M |
| 10 | Roivant Sciences Ltd | ROIV | 1.71% | 53.75K | $1.9M |
| 11 | Royalty Pharma PLC | RPRX | 1.69% | 33.15K | $1.9M |
| 12 | United Therapeutics Corp | UTHR | 1.57% | 3.20K | $1.8M |
| 13 | Incyte Corp | INCY | 1.52% | 15.10K | $1.7M |
| 14 | Guardant Health Inc | GH | 1.50% | 9.99K | $1.7M |
| 15 | Argenx SE | ARGNF | 1.49% | 2.02K | $1.7M |
| 16 | Insmed Inc | INSM | 1.46% | 16.25K | $1.6M |
| 17 | Viatris Inc | VTRS | 1.35% | 85.48K | $1.5M |
| 18 | Medpace Holdings Inc | MEDP | 1.13% | 2.06K | $1.3M |
| 19 | Exelixis Inc | EXEL | 0.99% | 18.43K | $1.1M |
| 20 | Neurocrine Biosciences Inc | NBIX | 0.96% | 7.56K | $1.1M |
| 21 | Jazz Pharmaceuticals PLC | JAZZ | 0.95% | 4.83K | $1.1M |
| 22 | Ascendis Pharma A/S | ASND | 0.94% | 4.58K | $1.0M |
| 23 | Summit Therapeutics Inc | SMMT | 0.94% | 59.37K | $1.0M |
| 24 | Bridgebio Pharma Inc | BBIO | 0.87% | 14.91K | $974.3K |
| 25 | BeOne Medicines Ltd | ONC | 0.84% | 2.66K | $943.6K |
| 26 | Halozyme Therapeutics Inc | HALO | 0.83% | 8.44K | $931.7K |
| 27 | Tempus AI Inc | TEM | 0.83% | 13.04K | $925.3K |
| 28 | BioNTech SE | BNTX | 0.75% | 8.63K | $836.8K |
| 29 | ImmunityBio Inc | IBRX | 0.74% | 78.79K | $828.0K |
| 30 | Madrigal Pharmaceuticals Inc | MDGL | 0.72% | 1.71K | $807.2K |
| 31 | BioMarin Pharmaceutical Inc | BMRN | 0.71% | 14.42K | $790.2K |
| 32 | Vaxcyte Inc | PCVX | 0.71% | 11.06K | $789.4K |
| 33 | Twist Bioscience Corp | TWST | 0.71% | 4.93K | $787.4K |
| 34 | Krystal Biotech Inc | KRYS | 0.66% | 2.21K | $732.9K |
| 35 | 10X Genomics Inc | TXG | 0.65% | 8.96K | $722.5K |
| 36 | Kymera Therapeutics Inc | KYMR | 0.62% | 6.18K | $694.5K |
| 37 | Protagonist Therapeutics Inc | PTGX | 0.62% | 4.82K | $692.6K |
| 38 | Arrowhead Pharmaceuticals Inc | ARWR | 0.59% | 10.53K | $660.8K |
| 39 | Axsome Therapeutics Inc | AXSM | 0.59% | 3.89K | $655.6K |
| 40 | Cytokinetics Inc | CYTK | 0.58% | 10.34K | $650.7K |
| 41 | Sanofi SA | SNY | 0.58% | 16.06K | $643.4K |
| 42 | Caris Life Sciences Inc | CAI | 0.56% | 21.02K | $624.4K |
| 43 | Spyre Therapeutics Inc | SYRE | 0.50% | 6.55K | $560.9K |
| 44 | Ionis Pharmaceuticals Inc | IONS | 0.50% | 12.35K | $559.3K |
| 45 | Praxis Precision Medicines Inc | PRAX | 0.48% | 2.06K | $536.6K |
| 46 | Amneal Pharmaceuticals Inc | AMRX | 0.46% | 25.90K | $515.7K |
| 47 | Alkermes PLC | ALKS | 0.45% | 12.50K | $507.5K |
| 48 | Iovance Biotherapeutics Inc | IOVA | 0.44% | 33.69K | $492.5K |
| 49 | Immunovant Inc | IMVT | 0.42% | 15.39K | $468.8K |
| 50 | Rhythm Pharmaceuticals Inc | RYTM | 0.42% | 5.13K | $465.6K |
| 51 | GRAIL Inc | GRAL | 0.42% | 3.31K | $465.3K |
| 52 | Kodiak Sciences Inc | KOD | 0.42% | 4.65K | $464.1K |
| 53 | Ligand Pharmaceuticals Inc | LGND | 0.41% | 1.50K | $453.3K |
| 54 | CG oncology Inc | CGON | 0.38% | 6.58K | $419.7K |
| 55 | Erasca Inc | ERAS | 0.37% | 26.04K | $417.5K |
| 56 | Mirum Pharmaceuticals Inc | MIRM | 0.37% | 4.83K | $415.7K |
| 57 | Oruka Therapeutics Inc | ORKA | 0.36% | 4.92K | $403.6K |
| 58 | PTC Therapeutics Inc | PTCT | 0.36% | 6.20K | $400.8K |
| 59 | Cogent Biosciences Inc | COGT | 0.36% | 12.91K | $400.3K |
| 60 | CRISPR Therapeutics AG | CRSP | 0.34% | 7.18K | $383.4K |
| 61 | Scholar Rock Holding Corp | SRRK | 0.34% | 9.06K | $382.2K |
| 62 | Abivax SA | ABVX | 0.34% | 4.25K | $374.3K |
| 63 | Definium Therapeutics Inc | DFTX | 0.33% | 10.00K | $369.0K |
| 64 | Travere Therapeutics Inc | TVTX | 0.33% | 7.03K | $366.2K |
| 65 | Edgewise Therapeutics Inc | EWTX | 0.28% | 8.07K | $315.3K |
| 66 | Adaptive Biotechnologies Corp | ADPT | 0.28% | 11.88K | $314.8K |
| 67 | Indivior Pharmaceuticals Inc | INDV | 0.28% | 8.77K | $314.3K |
| 68 | AbCellera Biologics Inc | ABCL | 0.27% | 24.13K | $302.7K |
| 69 | Tango Therapeutics Inc | TNGX | 0.27% | 12.55K | $298.9K |
| 70 | Relay Therapeutics Inc | RLAY | 0.26% | 16.28K | $291.1K |
| 71 | Kiniksa Pharmaceuticals International Plc | KNSA | 0.26% | 3.59K | $286.2K |
| 72 | Veracyte Inc | VCYT | 0.24% | 6.01K | $271.7K |
| 73 | Genmab A/S | GMAB | 0.24% | 7.20K | $266.9K |
| 74 | Amylyx Pharmaceuticals Inc | AMLX | 0.24% | 9.34K | $262.9K |
| 75 | Xenon Pharmaceuticals Inc | XENE | 0.23% | 7.19K | $262.0K |
| 76 | Ideaya Biosciences Inc | IDYA | 0.23% | 7.17K | $258.9K |
| 77 | ACADIA Pharmaceuticals Inc | ACAD | 0.23% | 12.82K | $253.6K |
| 78 | Tarsus Pharmaceuticals Inc | TARS | 0.23% | 3.44K | $251.7K |
| 79 | Arcutis Biotherapeutics Inc | ARQT | 0.22% | 9.34K | $248.3K |
| 80 | Denali Therapeutics Inc | DNLI | 0.21% | 11.91K | $231.7K |
| 81 | Dyne Therapeutics Inc | DYN | 0.21% | 13.89K | $231.2K |
| 82 | Enliven Therapeutics Inc | ELVN | 0.20% | 5.46K | $223.6K |
| 83 | Precigen Inc | PGEN | 0.19% | 26.58K | $207.6K |
| 84 | Beam Therapeutics Inc | BEAM | 0.18% | 7.68K | $197.5K |
| 85 | Newamsterdam Pharma Co NV | NAMS | 0.17% | 8.91K | $192.3K |
| 86 | MBX Biosciences Inc | MBX | 0.17% | 3.57K | $190.0K |
| 87 | Supernus Pharmaceuticals Inc | SUPN | 0.16% | 4.31K | $183.8K |
| 88 | Disc Medicine Inc | IRON | 0.16% | 2.87K | $178.2K |
| 89 | Harmony Biosciences Holdings Inc | HRMY | 0.16% | 4.33K | $174.3K |
| 90 | Recursion Pharmaceuticals Inc | RXRX | 0.16% | 39.82K | $173.6K |
| 91 | ADMA Biologics Inc | ADMA | 0.15% | 16.68K | $172.8K |
| 92 | Nurix Therapeutics Inc | NRIX | 0.15% | 7.72K | $172.5K |
| 93 | Aurinia Pharmaceuticals Inc | AUPH | 0.15% | 9.91K | $165.1K |
| 94 | BioCryst Pharmaceuticals Inc | BCRX | 0.15% | 19.06K | $163.0K |
| 95 | Pharvaris NV | PHVS | 0.15% | 5.23K | $162.6K |
| 96 | Vera Therapeutics Inc | VERA | 0.14% | 5.38K | $160.8K |
| 97 | Novavax Inc | NVAX | 0.14% | 12.33K | $157.2K |
| 98 | Structure Therapeutics Inc | GPCR | 0.14% | 6.10K | $155.9K |
| 99 | Mineralys Therapeutics Inc | MLYS | 0.14% | 6.56K | $153.3K |
| 100 | Vericel Corp | VCEL | 0.14% | 3.81K | $152.9K |
| 101 | Vir Biotechnology Inc | VIR | 0.13% | 12.64K | $147.9K |
| 102 | Fortrea Holdings Inc | FTRE | 0.13% | 7.10K | $147.9K |
| 103 | Alvotech SA | ALVO | 0.13% | 25.17K | $145.5K |
| 104 | Xeris Biopharma Holdings Inc | XERS | 0.13% | 13.56K | $142.2K |
| 105 | Agios Pharmaceuticals Inc | AGIO | 0.13% | 4.44K | $141.3K |
| 106 | Sarepta Therapeutics Inc | SRPT | 0.13% | 7.84K | $140.0K |
| 107 | Trevi Therapeutics Inc | TRVI | 0.13% | 10.59K | $139.6K |
| 108 | Intellia Therapeutics Inc | NTLA | 0.12% | 10.46K | $136.7K |
| 109 | Zymeworks Inc | ZYME | 0.12% | 5.26K | $135.8K |
| 110 | Xencor Inc | XNCR | 0.12% | 5.51K | $135.7K |
| 111 | UroGen Pharma Ltd | URGN | 0.12% | 3.64K | $134.0K |
| 112 | Septerna Inc | SEPN | 0.12% | 3.48K | $133.7K |
| 113 | Zenas Biopharma Inc | ZBIO | 0.12% | 4.85K | $132.2K |
| 114 | Absci Corp | ABSI | 0.12% | 12.79K | $129.9K |
| 115 | Personalis Inc | PSNL | 0.11% | 7.96K | $127.4K |
| 116 | Legend Biotech Corp | LEGN | 0.11% | 6.84K | $127.4K |
| 117 | Novocure Ltd | NVCR | 0.11% | 8.69K | $126.8K |
| 118 | ANI Pharmaceuticals Inc | ANIP | 0.11% | 1.69K | $124.9K |
| 119 | Ocular Therapeutix Inc | OCUL | 0.11% | 16.29K | $122.8K |
| 120 | Compass Pathways Plc | CMPS | 0.11% | 9.99K | $119.9K |
| 121 | Stoke Therapeutics Inc | STOK | 0.11% | 4.81K | $118.9K |
| 122 | Eton Pharmaceuticals Inc | ETON | 0.11% | 2.15K | $118.4K |
| 123 | uniQure NV | QURE | 0.10% | 5.16K | $116.6K |
| 124 | Innoviva Inc | INVA | 0.10% | 5.39K | $114.3K |
| 125 | Ultragenyx Pharmaceutical Inc | RARE | 0.10% | 7.32K | $113.4K |
| 126 | Syndax Pharmaceuticals Inc | SNDX | 0.10% | 6.67K | $113.2K |
| 127 | Maze Therapeutics Inc | MAZE | 0.10% | 4.13K | $111.9K |
| 128 | Rapport Therapeutics Inc | RAPP | 0.10% | 3.56K | $109.1K |
| 129 | Taysha Gene Therapies Inc | TSHA | 0.10% | 24.24K | $108.8K |
| 130 | GH Research PLC | GHRS | 0.10% | 5.12K | $108.0K |
| 131 | Pacira BioSciences Inc | PCRX | 0.10% | 2.95K | $107.2K |
| 132 | Omeros Corp | OMER | 0.10% | 5.40K | $107.1K |
| 133 | Inhibrx Biosciences Inc | INBX | 0.09% | 1.08K | $103.0K |
| 134 | AnaptysBio Inc | ANAB | 0.09% | 2.21K | $101.8K |
| 135 | Immunocore Holdings PLC | IMCR | 0.09% | 3.46K | $101.7K |
| 136 | Replimune Group Inc | REPL | 0.08% | 7.02K | $94.3K |
| 137 | ORIC Pharmaceuticals Inc | ORIC | 0.08% | 7.70K | $92.3K |
| 138 | Tyra Biosciences Inc | TYRA | 0.08% | 4.44K | $88.5K |
| 139 | Vor BioPharma Inc | VOR | 0.08% | 4.42K | $87.9K |
| 140 | Bicara Therapeutics Inc | BCAX | 0.08% | 4.92K | $86.0K |
| 141 | Amphastar Pharmaceuticals Inc | AMPH | 0.08% | 3.17K | $84.5K |
| 142 | First Tracks Biotherapeutics Inc | TRAX | 0.08% | 2.65K | $84.3K |
| 143 | Janux Therapeutics Inc | JANX | 0.08% | 4.57K | $84.1K |
| 144 | Zai Lab Ltd | ZLAB | 0.07% | 3.30K | $82.6K |
| 145 | Maravai LifeSciences Holdings Inc | MRVI | 0.07% | 11.09K | $82.5K |
| 146 | Harrow Inc | HROW | 0.07% | 2.81K | $82.4K |
| 147 | MannKind Corp | MNKD | 0.07% | 23.92K | $78.7K |
| 148 | Castle Biosciences Inc | CSTL | 0.07% | 2.28K | $78.6K |
| 149 | MeiraGTx Holdings plc | MGTX | 0.07% | 7.14K | $76.3K |
| 150 | Savara Inc | SVRA | 0.07% | 15.43K | $75.9K |
| 151 | Cullinan Therapeutics Inc | CGEM | 0.07% | 4.80K | $74.5K |
| 152 | Kura Oncology Inc | KURA | 0.06% | 6.68K | $70.8K |
| 153 | Alumis Inc | ALMS | 0.06% | 9.64K | $69.0K |
| 154 | Grifols SA | GRFS | 0.06% | 9.04K | $67.4K |
| 155 | Rigel Pharmaceuticals Inc | RIGL | 0.06% | 1.37K | $67.4K |
| 156 | Corvus Pharmaceuticals Inc | CRVS | 0.06% | 6.33K | $66.6K |
| 157 | Monte Rosa Therapeutics Inc | GLUE | 0.06% | 6.35K | $65.4K |
| 158 | Arbutus Biopharma Corp | ABUS | 0.06% | 14.86K | $62.7K |
| 159 | Sana Biotechnology Inc | SANA | 0.06% | 22.28K | $62.2K |
| 160 | Ardelyx Inc | ARDX | 0.05% | 18.66K | $61.2K |
| 161 | ArriVent Biopharma Inc | AVBP | 0.05% | 3.65K | $61.1K |
| 162 | Phibro Animal Health Corp | PAHC | 0.05% | 1.58K | $60.4K |
| 163 | Geron Corp | GERN | 0.05% | 47.45K | $58.1K |
| 164 | Annexon Inc | ANNX | 0.05% | 14.12K | $56.8K |
| 165 | Candel Therapeutics Inc | CADL | 0.05% | 5.71K | $56.8K |
| 166 | Mesoblast Ltd | MESO | 0.05% | 3.94K | $56.2K |
| 167 | Design Therapeutics Inc | DSGN | 0.05% | 4.71K | $54.9K |
| 168 | Solid Biosciences Inc | SLDB | 0.05% | 7.99K | $54.9K |
| 169 | Collegium Pharmaceutical Inc | COLL | 0.05% | 2.45K | $54.2K |
| 170 | 4D Molecular Therapeutics Inc | FDMT | 0.05% | 4.06K | $54.1K |
| 171 | Pacific Biosciences of California Inc | PACB | 0.05% | 23.14K | $53.9K |
| 172 | Prime Medicine Inc | PRME | 0.05% | 13.51K | $53.9K |
| 173 | OmniAb Inc | OABI | 0.05% | 10.89K | $52.2K |
| 174 | Olema Pharmaceuticals Inc | OLMA | 0.05% | 6.46K | $50.6K |
| 175 | Aura Biosciences Inc | AURA | 0.05% | 7.72K | $50.5K |
| 176 | Zevra Therapeutics Inc | ZVRA | 0.05% | 4.43K | $50.5K |
| 177 | Wave Life Sciences Inc | WVE | 0.04% | 14.51K | $50.2K |
| 178 | Invesco Government & Agency Portfolio | AGPXX | 0.04% | 48.07K | $48.1K |
| 179 | Ironwood Pharmaceuticals Inc | IRWD | 0.04% | 12.29K | $47.0K |
| 180 | Aquestive Therapeutics Inc | AQST | 0.04% | 9.44K | $45.1K |
| 181 | Phathom Pharmaceuticals Inc | PHAT | 0.04% | 6.05K | $43.8K |
| 182 | CorMedix Inc | CRMD | 0.04% | 5.80K | $42.8K |
| 183 | Aclaris Therapeutics Inc | ACRS | 0.04% | 10.96K | $42.0K |
| 184 | CytomX Therapeutics Inc | CTMX | 0.04% | 16.07K | $41.3K |
| 185 | Sagimet Biosciences Inc | SGMT | 0.04% | 4.60K | $41.0K |
| 186 | Neurogene Inc | NGNE | 0.04% | 1.51K | $39.8K |
| 187 | REGENXBIO Inc | RGNX | 0.04% | 4.90K | $39.6K |
| 188 | Puma Biotechnology Inc | PBYI | 0.04% | 3.83K | $39.4K |
| 189 | Evolus Inc | EOLS | 0.03% | 4.95K | $38.3K |
| 190 | Altimmune Inc | ALT | 0.03% | 14.48K | $37.8K |
| 191 | Allogene Therapeutics Inc | ALLO | 0.03% | 25.73K | $37.6K |
| 192 | Arvinas Inc | ARVN | 0.03% | 4.88K | $37.3K |
| 193 | Kamada Ltd | KMDA | 0.03% | 4.39K | $35.5K |
| 194 | Alpha Teknova Inc | TKNO | 0.03% | 3.98K | $35.2K |
| 195 | Silence Therapeutics PLC | SLN | 0.03% | 3.55K | $35.0K |
| 196 | Lakefront Biotherapeutics NV | GLPGF | 0.03% | 1.15K | $34.3K |
| 197 | Prothena Corp PLC | PRTA | 0.03% | 3.83K | $33.8K |
| 198 | Editas Medicine Inc | EDIT | 0.03% | 11.65K | $33.8K |
| 199 | Contineum Therapeutics Inc | CTNM | 0.03% | 2.47K | $33.1K |
| 200 | Tectonic Therapeutic Inc | TECX | 0.03% | 1.40K | $32.7K |
| 201 | ARS Pharmaceuticals Inc | SPRY | 0.03% | 7.40K | $31.3K |
| 202 | Atea Pharmaceuticals Inc | AVIR | 0.03% | 6.08K | $31.3K |
| 203 | Arcturus Therapeutics Holdings Inc | ARCT | 0.03% | 2.15K | $29.6K |
| 204 | Kyverna Therapeutics Inc | KYTX | 0.03% | 4.60K | $29.4K |
| 205 | C4 Therapeutics Inc | CCCC | 0.03% | 9.14K | $28.9K |
| 206 | Enanta Pharmaceuticals Inc | ENTA | 0.02% | 2.18K | $27.2K |
| 207 | Autolus Therapeutics PLC | AUTL | 0.02% | 14.92K | $27.0K |
| 208 | Orchestra BioMed Holdings Inc | OBIO | 0.02% | 4.48K | $26.7K |
| 209 | Cabaletta Bio Inc | CABA | 0.02% | 12.31K | $23.8K |
| 210 | Quantum-Si Inc | QSI | 0.02% | 14.53K | $22.2K |
| 211 | BioAge Labs Inc | BIOA | 0.02% | 3.49K | $22.1K |
| 212 | Fulcrum Therapeutics Inc | FULC | 0.02% | 5.70K | $21.5K |
| 213 | EyePoint Inc | EYPT | 0.02% | 6.27K | $21.3K |
| 214 | Rocket Pharmaceuticals Inc | RCKT | 0.02% | 8.15K | $20.9K |
| 215 | Larimar Therapeutics Inc | LRMR | 0.02% | 7.73K | $20.6K |
| 216 | Vanda Pharmaceuticals Inc | VNDA | 0.02% | 4.50K | $20.6K |
| 217 | Lexeo Therapeutics Inc | LXEO | 0.02% | 6.01K | $19.4K |
| 218 | Upstream Bio Inc | UPB | 0.02% | 4.09K | $19.2K |
| 219 | Immuneering Corp | IMRX | 0.02% | 4.82K | $19.0K |
| 220 | AC Immune SA | ACIU | 0.02% | 7.55K | $18.9K |
| 221 | Lifecore Biomedical Inc | LNDC | 0.02% | 2.80K | $18.1K |
| 222 | Keros Therapeutics Inc | KROS | 0.02% | 1.50K | $18.0K |
| 223 | SIGA Technologies Inc | SIGA | 0.02% | 5.37K | $17.6K |
| 224 | Entrada Therapeutics Inc | TRDA | 0.01% | 2.90K | $16.4K |
| 225 | Sionna Therapeutics Inc | SION | 0.01% | 3.35K | $16.4K |
| 226 | Invivyd Inc | ADGI | 0.01% | 21.94K | $15.8K |
| 227 | Lyell Immunopharma Inc | LYEL | 0.01% | 1.75K | $15.3K |
| 228 | PepGen Inc | PEPG | 0.01% | 5.16K | $13.5K |
| 229 | Bicycle Therapeutics PLC | BCYC | 0.01% | 3.46K | $13.5K |
| 230 | Pyxis Oncology Inc | PYXS | 0.01% | 6.20K | $12.6K |
| 231 | Coherus Oncology Inc | CHRS | 0.01% | 11.51K | $12.3K |
| 232 | Jyong Biotech Ltd | MENS | 0.01% | 5.55K | $11.7K |
| 233 | NovaBridge Biosciences | IMAB | 0.01% | 8.29K | $11.6K |
| 234 | Codexis Inc | CDXS | 0.01% | 8.14K | $11.5K |
| 235 | Voyager Therapeutics Inc | VYGR | 0.01% | 4.46K | $10.9K |
| 236 | Anavex Life Sciences Corp | AVXL | 0.01% | 6.88K | $10.3K |
| 237 | CASH & EQUIVALENTS | — | 0.01% | 9.23K | $9.2K |
| 238 | Tenaya Therapeutics Inc | TNYA | 0.01% | 15.90K | $9.2K |
| 239 | Foghorn Therapeutics Inc | FHTX | 0.01% | 4.43K | $8.9K |
| 240 | Humacyte Inc | HUMA | 0.01% | 20.67K | $8.4K |
| 241 | LENZ Therapeutics Inc | LENZ | 0.01% | 2.29K | $8.3K |
| 242 | Black Diamond Therapeutics Inc | BDTX | 0.01% | 4.20K | $7.7K |
| 243 | Aardvark Therapeutics Inc | AARD | 0.01% | 1.60K | $7.6K |
| 244 | Rani Therapeutics Holdings Inc | RANI | 0.01% | 8.29K | $6.6K |
| 245 | Neumora Therapeutics Inc | NMRA | 0.01% | 13.35K | $6.4K |
| 246 | Gossamer Bio Inc | GOSS | 0.00% | 436 | $4.1K |
| 247 | Caribou Biosciences Inc | CRBU | 0.00% | 7.33K | $3.4K |
| 248 | Cartesian Therapeutics Inc 12/31/2050 | — | 0.00% | 2.63K | $359.22 |
| 249 | USD Pending Dividends | — | 0.00% | 0 | $39.98 |
| 250 | SECURITIES LENDING - BNYM | — | 0.00% | 1 | $0.01 |
| 251 | OmniAb Inc 11/02/2027 | — | 0.00% | 125 | $0.00 |
| 252 | Novo Nordisk A/S 06/30/2031 | — | 0.00% | 3.79K | $0.00 |
| 253 | Esperion Therapeutics Inc 03/15/2028 | — | 0.00% | 13.22K | $0.00 |
| 254 | OmniAb Inc 11/02/2027 | — | 0.00% | 125 | $0.00 |
| 255 | Coherus Oncology Inc 12/31/2050 | — | 0.00% | 10.94K | $0.00 |
| 256 | Eli Lilly & Co | — | 0.00% | 6.34K | $0.00 |
| 257 | Third Harmonic Bio Inc | THRD | 0.00% | 1.60K | $0.00 |
티커를 클릭하면 해당 종목을 보유한 모든 ETF를 볼 수 있습니다.
섹터 노출
지역별 익스포저
데이터 제공업체가 보고한 국가별 비중. 선진국/신흥국/프런티어 분류는 방법론 페이지의 기준을 따릅니다. 환헤지: 펀드명에 헤지 표시 없음.
분배금
| 수익률 (TTM) | 1.13% | 지급액 (최근 12개월) | $0.3913 |
| 발표 주기 | Quarterly | SEC 수익률 | 데이터 소스에서 제공하지 않는 정보입니다. 운용사 페이지를 확인하세요 |
| 최근 배당락일 | Sep 21, 2026 | 최근 지급일 | $0.2304 (Sep 25, 2026) |
| 1년 성장률 | +72.69% | 3년 / 5년 성장률 (연환산) | +33.03% / — |
| 배당락일 | 배당락일 | 지급일 | 금액 |
|---|---|---|---|
| Sep 21, 2026 | Sep 21, 2026 | Sep 25, 2026 | $0.2304 |
| Jun 22, 2026 | Jun 22, 2026 | Jun 26, 2026 | $0.0342 |
| Mar 23, 2026 | Mar 23, 2026 | Mar 27, 2026 | $0.0361 |
| Dec 22, 2025 | Dec 22, 2025 | Dec 26, 2025 | $0.0906 |
| Sep 22, 2025 | Sep 22, 2025 | Sep 26, 2025 | $0.0958 |
| Jun 23, 2025 | Jun 23, 2025 | Jun 27, 2025 | $0.0287 |
| Mar 24, 2025 | Mar 24, 2025 | Mar 28, 2025 | $0.0402 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 27, 2024 | $0.0619 |
| Sep 23, 2024 | Sep 23, 2024 | Sep 27, 2024 | $0.0894 |
| Jun 24, 2024 | Jun 24, 2024 | Jun 28, 2024 | $0.0506 |
| Mar 18, 2024 | Mar 19, 2024 | Mar 22, 2024 | $0.0435 |
| Dec 18, 2023 | Dec 19, 2023 | Dec 22, 2023 | $0.0526 |
분배금 후행 수익률 = 최근 12개월 현금 분배금 ÷ 현재 가격. SEC 30일 수익률이 아니며, 분배금의 지속이 보장되지 않습니다. 차이의 이해 →
위험 통계
| 변동성 1년 / 3년 | 21.90% / 21.04% | 샤프 지수 1년 / 3년 | 1.72 / 0.982 |
| 최대 낙폭 1년 / 3년 | -8.69% / -23.71% | 소르티노 지수 1년 | 2.73 |
| S&P 500 대비 베타 (3년) | 0.752 | S&P 500 대비 상관관계 (1년) | 0.429 |
| 하방 편차 1년 | 13.80% | 사용된 무위험 수익률 | 4.05% (3M T-bill, FRED) |
산출 기준: ETF Explorer 일별 배당 조정 종가 기준; 변동성 및 낙폭은 연환산/기간 수치; S&P 500 익스포저는 SPY로 근사치 산출. 기준일 Oct 12, 2026. 계산식 →
유동성
| 오늘의 거래량 | 19.03K | 평균 거래량 | 32.11K |
| AUM | $111.7M | 프리미엄/디스카운트 | -0.85% |
| 매수/매도 스프레드 | 당사 데이터 소스에서 제공하지 않습니다. 브로커의 시세 화면을 확인하세요. 스프레드는 장 시작과 마감 시점에 가장 넓어집니다. | ||
프리미엄/디스카운트는 지연된 시장 가격과 최근 보고된 NAV를 비교한 참고 수치이며, 공식 종가 기준 프리미엄/디스카운트가 아닙니다. ETF 유동성 구조 →
자금 흐름 (추정)
| 기간 | 추정 순 플로우 | 초기 AUM의 % | AUM 시작 → 종료 |
|---|---|---|---|
| 1일 | $3.4M | +3.14% | $108.3M → $111.7M |
| 1개월 | $14.2M | +14.66% | $97.0M → $111.7M |
| 1주 | $5.6M | +5.28% | $106.4M → $111.7M |
ETF Explorer 추정치: 자체 일별 AUM 스냅샷을 기준으로, 보고된 AUM 변화에서 시장 움직임의 영향을 제외한 값입니다. 운용사의 공식 설정/환매 데이터가 아닙니다.
펀드 공식 자료
외부 링크는 운용사 사이트 또는 SEC EDGAR를 새 탭에서 엽니다. 투자 설명서 및 공식 문서가 항상 최우선 참고 자료이므로, 투자 전에 반드시 검토하시기 바랍니다.
최신 뉴스 — IBBQ
최근 7일간 이 펀드를 직접 언급한 기사가 없습니다. 일반 ETF 관련 기사를 표시합니다.
Webinar: Mitigating Market Concentration Risk With RAFI Indices ↗
In a recent webcast hosted by TMX VettaFi's Head of Research Todd Rosenbluth, Ari Polychronopoulos, TMX VettaFi's head of RAFI Indices joined Brent…
ETF Trends · Oct 12, 14:33 UTC
Biotech’s Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism ↗
Biotechnology stocks are showing signs of a renewed recovery, supported by a pickup in pharmaceutical mergers and acquisitions and investor interest…
ETF Trends · Oct 12, 14:33 UTC
EU looking at oil and gas windfall profit tax, as energy prices soar ↗
EU looking at oil and gas windfall profit tax, as energy prices soar
Reuters · Oct 12, 13:48 UTC
4Q’26 Defense Sector Guide: Opportunities Amid Instability ↗
Each quarter, SPADE Indexes releases The SPADE Investor, covering trends, statistics, and analysis across the defense, aerospace, national security…
ETF Trends · Oct 12, 13:33 UTC
Wall Street's big but narrow rally: 4 in 10 S&P stocks are down this year ↗
The gap between the benchmark and its average member highlights how much of Wall Street's rally rests on a handful of companies as the US bull market…
New York Post · Oct 12, 13:06 UTC
Why Higher Rates Haven’t Broken the Stock Market ↗
For most of the past year, investors have been trying to answer what seems like a fairly straightforward question: How can the stock market continue…
ETF Trends · Oct 12, 12:31 UTC
관련 전체 뉴스: IBBQ →
도움말: AUM은 펀드 규모를 의미합니다. 보수율(expense ratio)은 수익률에 반영되는 연간 비용입니다. NAV는 펀드가 보유한 자산의 주당 가치이며, 시장 가격은 NAV보다 약간 높거나(프리미엄) 낮을(디스카운트) 수 있습니다. 총수익률은 분배금이 재투자되었다고 가정합니다. 보유 종목, 자산, 시세는 업데이트 일정이 각각 다르므로 데이터셋마다 기준일이 표시됩니다.